Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Helman

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2017
Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and HepatoblastomaJennifer M Kalish, Leslie Doros, Lee J Helman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2016
Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription FactorChristy L Osgood, Nichole Maloney, Christopher G Kidd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration studyAlberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.
Cancer|May 7, 2014
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration studyAlberto S Pappo, Gilles Vassal, John J Crowley, et al.
Sarcoma|November 16, 2017
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath TumorsChristine S Higham, Seth M Steinberg, Eva Dombi, et al.
Science Translational Medicine|February 5, 2016
Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative OncologyAmy K LeBlanc, Matthew Breen, Peter Choyke, et al.
Leukemia|February 16, 2016
The TCA cycle transferase DLST is important for MYC-mediated leukemogenesisN M Anderson, D Li, H L Peng, et al.
Science Translational Medicine|December 26, 2014
Recurrent epimutation of SDHC in gastrointestinal stromal tumorsJ Keith Killian, Markku Miettinen, Robert L Walker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in RhabdomyosarcomaSrivandana Akshintala, R Taylor Sundby, Donna Bernstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1Paul F Robbins, Richard A Morgan, Steven A Feldman, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2017
Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and HepatoblastomaJennifer M Kalish, Leslie Doros, Lee J Helman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2016
Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription FactorChristy L Osgood, Nichole Maloney, Christopher G Kidd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration studyAlberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.
Cancer|May 7, 2014
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration studyAlberto S Pappo, Gilles Vassal, John J Crowley, et al.
Sarcoma|November 16, 2017
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath TumorsChristine S Higham, Seth M Steinberg, Eva Dombi, et al.
Science Translational Medicine|February 5, 2016
Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative OncologyAmy K LeBlanc, Matthew Breen, Peter Choyke, et al.
Leukemia|February 16, 2016
The TCA cycle transferase DLST is important for MYC-mediated leukemogenesisN M Anderson, D Li, H L Peng, et al.
Science Translational Medicine|December 26, 2014
Recurrent epimutation of SDHC in gastrointestinal stromal tumorsJ Keith Killian, Markku Miettinen, Robert L Walker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in RhabdomyosarcomaSrivandana Akshintala, R Taylor Sundby, Donna Bernstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1Paul F Robbins, Richard A Morgan, Steven A Feldman, et al.
Pageof 22